Corton Capital’s PetMed Express PETS Stock Holding History

Corton Capital’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-13,539	Closed	-$102K	–	626
2023 Q4	$102K	Buy	+13,539	New	+$111K	0.03%	547

Other funds holding PETS

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Corton Capital's PETS Position: Q1 2024 in Review

Corton Capital sold out of PetMed Express (PETS) in Q1 2024, closing a stake of 13,539 shares — an estimated $102K sold.

Corton Capital first reported a position in PETS in Q4 2023 and held it in 1 quarter. The position peaked at $102K in Q4 2023. 116 funds tracked by Wall St. Rank hold PETS as of Q1 2024.

Corton Capital reported no remaining PetMed Express position as of Q1 2024 after selling out during the quarter.
Corton Capital sold 13,539 PetMed Express shares in Q1 2024, an estimated $102K.
Corton Capital first reported a position in PetMed Express in Q4 2023 and held it in 1 quarter.
Corton Capital's PetMed Express position peaked at $102K in Q4 2023.
116 funds tracked by Wall St. Rank held PetMed Express as of Q1 2024.

Based on Corton Capital's 13F filing for Q1 2024, filed 15 May 2024.